The Division of Haematology is a subspecialised unit within the Department of Medicine which deals with general haematology and haemato-oncological disorders. It is also a tertiary and quaternary referral centre for blood diseases.
The division consists of consultants and specialist trainees in general haematology, haemato-oncological disorders and haematopoietic stem cell transplantation. The following diseases and conditions are managed by our division:
The division has a close working relationship with haematopathologists, histopathologists, blood bank and transfusion medicine specialists, radiologists, oncologists, other subspecialties in internal medicine and surgeons.
Services provided are as follows
Haematology Ward 6D (ext: 2741)
The haematology ward is located at the 6th floor of Menara Timur UMMC. There are 21 beds for patients that require inpatient haematology care including 4 beds allocated for patients undergoing HSCT.
Haematology Daycare Unit (ext: 2952)
The haematology daycare unit is located adjacent to the haematology ward at the 6th floor of Menara Timur UMMC. Patients needing regular outpatient review as well as those requiring transfusion and chemotherapy seen here.
Haematology Outpatient Clinic (ext: 3859)
The haematology outpatient clinic is located at ‘KlinikPerubatan 2’ Menara Utama UMMC. Consultation days are every Friday 8am – 12pm. Patients requiring follow up and new case referrals for haematological diseases are seen here.
Bone Marrow Transplant Clinic (ext: 3859)
The haematology outpatient clinic is located at ‘KlinikPerubatan 2’ Menara Utama UMMC. Consultation days are every Monday 2 – 3pm. Patients requiring follow up after transplant and new case referrals for transplant are seen here.
Teaching and training
The unit provides teaching and training for undergraduate and postgraduate students as well as house officers, medical officers and specialist trainees in the following
The division is actively involved in research in all aspects of haematological disorders and HSCT and these have been presented and published at both national and international levels.
The division is involved in multiple phase III multicentre Clinical Trials, recruiting patients who are managed at UMMC.